ascendis pharma glp-1 receptor agonist agonists for individualized treatment of type 2 diabetes mellitus Glucagon-like peptide-1 receptor: mechanisms and

Neurodegenerative diseases, including Alzheimers Disease (AD) and Parkinsons Disease (PD) are common complications of diabetes, arising from insulin resistance, inflammation, and other pathological processes in the central nervous system

In an investigative report in partnership with KFF Health News, NBC News Anne Thompson reports on the growing cases of overdoses involving GLP-1 weight loss drugs.

Ozempic alternatives in the GLP-1 family offer effective weight loss pathways

GLP-1 and its synthetic analogs have emerged as significant therapeutic agents for the management of metabolic disorders, merging glycemic control with weight loss through innovative structural and delivery breakthroughs

GLP-1 is of relevance to ...